Antibiotics Could Save Thousands from Unnecessary Surgery

A century-old medical tradition faces an unexpected challenge from something as simple as a course of antibiotics, potentially sparing hundreds of thousands of patients from the operating room each year.

Story Snapshot

Clinical trials show 70-92% of uncomplicated appendicitis cases resolve with antibiotics alone, eliminating the need for emergency surgery
Despite strong evidence and international guideline support, surgeons in the United States and Europe continue defaulting to surgery as first-line treatment
Antibiotic treatment delivers fewer complications, shorter hospital stays, and substantial cost savings compared to traditional appendectomy
Patient selection remains critical, with cases involving appendicolith requiring surgical intervention
The disconnect between evidence and practice reveals deep institutional resistance to changing established protocols

When Evidence Meets Resistance

Appendectomy has reigned as the gold standard treatment for acute appendicitis since the late 1800s. Surgeons have performed millions of these procedures, perfecting the technique to the point where laparoscopic appendectomy became routine. Yet major clinical trials conducted over the past decade tell a surprising story. The APPAC trial in Finland demonstrated a 71% success rate with antibiotics alone. The CODA trial pushed that figure to 84%. Most recently, the APPAC II trial confirmed that even oral antibiotics by themselves achieved over 70% success at one-year follow-up, opening the door to potential outpatient management.

The Numbers Tell a Compelling Story

A large multicentre cohort study documented an 80% non-operative success rate by 90 days after initial presentation. Pediatric patients fared even better, with studies showing 89-92% initial symptom remission rates and only 5% experiencing recurrence during one-year follow-up. These figures demolish the assumption that surgery represents the only reliable solution. The cost implications prove equally dramatic. Antibiotic treatment reduces hospitalization time, eliminates surgical complications, and delivers what researchers describe as major cost savings compared to operative management.

Why Surgeons Still Reach for the Scalpel

International guidelines now recommend antibiotics as a safe and effective alternative to surgery for uncomplicated acute appendicitis without faecolith. Yet laparoscopic appendectomy remains the first-line treatment in Europe and the United States. This implementation gap reveals something fundamental about medical practice: evidence alone does not change behavior. Surgical tradition carries immense weight. Training programs emphasize technical proficiency in appendectomy. Hospital systems have established protocols built around surgical intervention. Emergency departments reflexively consult surgery when imaging confirms appendicitis.

Dr. Wesley Self at Vanderbilt University Medical Center acknowledges that an antibiotics-first approach can help patients recover without surgery, but emphasizes it does not work for everyone. Patients with appendicolith, a calcified deposit within the appendix, frequently fail antibiotic treatment and require surgical intervention. This limitation demands careful patient selection through proper imaging, something that requires time and expertise in busy emergency departments already operating under resource constraints.

The Patient Selection Problem

Determining which patients qualify for antibiotic treatment requires distinguishing uncomplicated from complicated appendicitis, identifying the presence of appendicolith, and assessing patient reliability for follow-up care. Emergency physicians must weigh these factors against the pressure to provide definitive treatment quickly. Surgery offers certainty: the inflamed appendix gets removed, problem solved. Antibiotics introduce variables: Will this patient respond? Will they return if symptoms worsen? Can they reliably take medications and monitor their condition at home?

Dr. Peter Minneci at Nemours Children’s Health describes nonoperative management as a safe and cost-effective initial therapy and a reasonable alternative to surgery. The word “reasonable” captures the complexity physicians face. Antibiotic treatment represents a reasonable choice, not necessarily the obvious or required choice. This ambiguity leaves room for surgical tradition to maintain its grip on clinical decision-making, even when evidence supports a less invasive approach.

The Contrarian Voice Worth Hearing

Stanford researchers present a contrasting perspective, arguing that treating appendicitis with antibiotics alone proves more costly and results in higher hospital readmission rates. This dissenting view deserves consideration, though the methodology appears less robust than the comprehensive cohort studies and randomized controlled trials supporting antibiotic efficacy. The Stanford perspective may reflect older data or different patient populations. However, their caution highlights genuine concerns about treatment failure, recurrence, and the potential for delayed surgery under worse conditions.

University of Michigan researchers note that antibiotics may totally resolve the appendicitis or at least delay the need for surgery. This flexibility represents both an advantage and a complication. Patients and families must accept uncertainty, understanding that antibiotics might work completely, might provide temporary relief, or might fail entirely. American healthcare consumers, accustomed to aggressive intervention and definitive solutions, may struggle with this probabilistic approach to treatment.

What Remains Unknown

Researchers identify several gaps requiring additional investigation. Long-term antibiotic resistance implications need documentation, particularly given concerns about overuse contributing to resistant bacterial strains. The potential for Clostridioides difficile colitis following antibiotic treatment requires monitoring. Optimal protocols for outpatient management await development and validation. These unknowns provide ammunition for skeptics who prefer the devil they know: surgery may be invasive, but its outcomes are well-documented and predictable.

The implementation barrier proves most puzzling. When clinical evidence consistently demonstrates safety, efficacy, and cost-effectiveness, why do practice patterns lag so dramatically behind guidelines? The answer likely involves multiple factors: surgical department economics that depend on procedure volume, physician training that emphasizes technical skills over conservative management, liability concerns that favor aggressive intervention, and simple institutional inertia that resists changing established workflows.

The Path Forward

Appendicitis remains the fifth most common reason for hospitalization among children in the United States, and appendectomy remains the most common surgical procedure performed during pediatric inpatient hospitalizations. These numbers represent enormous opportunity for reducing unnecessary surgery, improving patient outcomes, and controlling healthcare costs. The evidence supporting antibiotic treatment has reached critical mass. Multiple independent trials across different populations and healthcare systems demonstrate consistent results.

What changes medical practice is not merely evidence, but evidence combined with shifts in physician culture, patient expectations, institutional protocols, and economic incentives. Emergency departments need decision support tools helping physicians identify appropriate candidates for antibiotic treatment. Surgical departments need reorientation toward managing complicated cases while supporting non-operative approaches for uncomplicated appendicitis. Hospital systems need protocol changes that default toward antibiotics unless clear contraindications exist.